IP Library Granted Patent US 9,283,399
Granted Patent B2
US 9,283,399 · App. 14/175,433 · Granted Mar 15, 2016

Wearable medical treatment device

Inventors: Edward J. Donnelly (Allison Park, PA); Thomas E. Kaib (North Huntingdon, PA); Marshal W. Linder (New Kensington, PA); Steven J. Szymkiewicz (Bethel Park, PA); Jason T. Whiting (Gibsonia, PA); Shane S. Volpe (Saltsburg, PA)
Assignee: ZOLL MEDICAL CORPORATION
A61N1/3987A61B5/02055A61B5/11A61B5/1112A61B5/1117A61B5/6805A61N1/0484A61N1/36585A61N1/37258A61N1/39A61N1/3993A61B5/021A61B5/02438A61B5/04085A61B5/0816A61B5/1455A61B5/721A61B2560/045A61N1/36535A61N1/36542A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,399
App. No.
14/175,433
Granted
Mar 15, 2016
Kind
B2
Abstract

A wearable treatment device includes a cardiac sensing electrode, a treatment electrode, a user interface, and a sensor. The cardiac sensing electrode detects cardiac information, and the treatment electrode applies treatment to a subject. The user interface receives quality of life information from the subject, and the sensor detects subject activity and wellness information. A controller coupled with the cardiac sensing electrode, the treatment electrode, the user interface, and the sensor receives the detected cardiac information, the quality of life information, and the detected subject activity and wellness information, and determines that treatment is to be applied to the body of the subject based upon the detected cardiac to information. The controller can adjust the treatment based on at least one of the detected subject activity and wellness information and the quality of life information.

Claims (29)

1. A wearable treatment device, comprising:

a plurality of cardiac sensing electrodes configured to be positioned outside a body of a subject and to detect cardiac information of the subject;

a treatment electrode configured to be positioned outside the body of the subject and to apply treatment to the subject;

a monitor configured to administer a predetermined test to the subject and having a user interface configured to receive quality of life information from the subject;

at least one motion sensor configured to be positioned outside the body of the subject and to detect subject motion during the predetermined test; and

a controller communicatively coupled to the plurality of cardiac sensing electrodes, the treatment electrode, the monitor, and the at least one motion sensor, the controller configured to receive and store the detected cardiac information, the quality of life information, and the detected subject motion, and to communicate the stored detected subject motion and the quality of life information to a remote computer.

2. The wearable treatment device of claim 1 , wherein the quality of life information identifies at least one of a fatigue level and a breathing level of the subject.

3. The wearable treatment device of claim 1 , wherein the quality of life information identifies a fatigue level and a breathing level of the subject.

4. The wearable treatment device of claim 3 , wherein the predetermined test is a six minute walk test.

5. The wearable treatment device of claim 4 , wherein the at least one motion sensor includes at least one accelerometer.

6. The wearable treatment device of claim 5 , wherein the controller determines a distance traveled by the subject during the six minute walk test based upon the detected subject motion from the at least one accelerometer.

7. The wearable treatment device of claim 6 , further comprising at least one additional sensor communicatively coupled to the controller to detect at least one of blood pressure, blood oxygen level, respiration, and temperature.

8. The wearable treatment device of claim 7 , wherein the controller wirelessly communicates the stored detected subject motion and the quality of life information to the remote computer.

9. The wearable treatment device of claim 4 , wherein the at least one motion sensor includes a pedometer, and wherein the controller determines a distance traveled by the subject during the six minute walk test based upon the detected subject motion from the pedometer.

10. The wearable treatment device of claim 4 , further comprising at least one additional sensor communicatively coupled to the controller to detect at least one of blood pressure, blood oxygen level, respiration, and temperature.

11. The wearable treatment device of claim 4 , wherein the quality of life information further includes information about at least one of the subject's lifestyle, body weight, blood pressure, eating and exercise habits, and how the subject currently feels.

12. The wearable treatment device of claim 1 , wherein the predetermined test is a six minute walk test, and wherein the at least one motion sensor includes at least one accelerometer.

13. The wearable treatment device of claim 12 , further comprising at least one additional sensor communicatively coupled to the controller to detect at least one of blood pressure, blood oxygen level, respiration, and temperature.

14. The wearable treatment device of claim 1 , wherein the predetermined test is a six minute walk test, and wherein the at least one motion sensor includes a pedometer.

15. The wearable treatment device of claim 1 , wherein the predetermined test is a six minute walk test, and wherein the at least one motion sensor includes at least one of an accelerometer and a pedometer.

16. The wearable treatment device of claim 15 , wherein the user interface is configured to guide the subject through the predetermined test.

17. The wearable treatment device of claim 15 , further comprising at least one additional sensor communicatively coupled to the controller to detect at least one of blood pressure, blood oxygen level, respiration, and temperature.

18. The wearable treatment device of claim 1 , wherein the quality of life information identifies a fatigue level and a breathing level of the subject.

19. The wearable treatment device of claim 18 , wherein the quality of life information is received from the subject in response to questions posed to the subject via the user interface of the monitor.

20. The wearable treatment device of claim 1 , wherein the quality of life information is received from the subject in response to questions posed to the subject via the user interface of the monitor.

21. The wearable treatment device of claim 20 , wherein the questions are posed to the subject at selectable intervals.

22. The wearable treatment device of claim 1 , wherein the user interface is configured to guide the subject through the predetermined test.

23. The wearable treatment device of claim 1 , wherein the user interface is configured to prompt the subject to perform the predetermined test.

24. The wearable treatment device of claim 1 , wherein the user interface is configured to prompt the subject to provide the quality of life information.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2017
From: DONNELLY, EDWARD J; KAIB, THOMAS E; LINDER, MARSHAL W; SZYMKIEWICZ, STEVEN J; WHITING, JASON T; VOLPE, SHANE
To: ZOLL MEDICAL CORPORATION
Reel/Frame 043793/0787 →
Continuity (5)
Continuation 13416734 · Mar 9, 2012
Continuation 12833173 · Jul 9, 2010
Continuation In Part 12002469 · Dec 17, 2007
Provisional Application 60934404 · Jun 13, 2007
Related Publication 20140303680A1 · Oct 9, 2014